Brief: Royalty Pharma To Acquire Royalty Interest In Geron’S RYTELO For $125 Mln
Nov 7 (Reuters) - Geron Corp GERN.O :
* ROYALTY PHARMA TO ACQUIRE ROYALTY INTEREST IN GERON’S
RYTELO FOR
$125 MILLION
* ROYALTY PHARMA PLC -DEAL INCREASES SYNTHETIC ROYALTY
FUNDING TO
$925 MILLION IN 2024
Source text: ID:nGNXs5fdM
Further company coverage: GERN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Geron
See all newsBrief: Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Geron Corporation reports results for the quarter ended June 30 - Earnings Summary
Geron's Q2 revenue rises on RYTELO growth
Brief: Geron Q2 EPS USD -0.02
Brief: Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)